Study reveals new aptamer targeting tool can detect early signs of motor neurone disease
The fatal, progressive neurological condition currently affects around 5,000 people in the UK
Read More
Tag: University of Aberdeen
Industry research boost from University of Aberdeen
The programme will support new European and national strategies to reduce exposure to hazardous chemicals
Read More
Scientists awarded £1m to help women make childbirth choices
Group will develop an aid that can be used to guide discussion between pregnant women
Read More
Key blood clotting protein could be ‘warning light’ for COVID-19 cases
University of Aberdeen team suggest results indicate that protein PAI-1 could be an early indicator of severe COVID-19
Read More
First treatment for ‘broken heart syndrome’ trialled
Scientists will trial a programme of exercise conditioning and psychological therapy for people diagnosed with the condition
Read More
University of Aberdeen study finds diabetes almost doubles risk of COVID-19 death
Researchers reviewed findings from 158 global studies to determine how COVID-19 affects people living with diabetes
Read More
Researchers develop COVID-19 antibody test to detect new variants
New antibody tests can detect if an individual has been exposed to COVID-19 variants, including Alpha and Delta variants
Read More
Researchers to test heart drug for COPD patients
University of Aberdeen researchers are set to test beta-blockers for COPD patients.
Read More
Rural patients less likely to survive cancer, study finds
A new study has shown that people who live in rural areas are less likely to survive cancer than those who live in cities.
Read More
Aberdeen Uni leads £1.1m study on bleeding plug
A £1.1-million study led by the University of Aberdeen is trialling a new technique that aims to control life-threatening bleeding in trauma victims.
Read More
Contraceptive pill reduces cancer risk long-term, study finds
Women who have taken the oral contraceptives seem have a reduced risk of developing some types of cancer for as long as thirty years, suggests new research from The University of Aberdeen, published in the American Journal of Obstetrics and Gynaecology.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
